AVASTART - Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer
| Status: | Archived |
|---|---|
| Conditions: | Colorectal Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | January 2010 |
| End Date: | January 2013 |
This observational study will assess the treatment duration, progression-free survival,
reason for stopping treatment and patient and tumor characteristics of bevacizumab [Avastin]
treatment in patients with metastatic colorectal cancer. Data will be collected for
approximately 34 months. The target sample size is >300 patients.
We found this trial at
1
site
Click here to add this to my saved trials
